After being found unresponsive in a park, a 47-year-old man is transported to your facility—and you recognize him as a patient who left against...
For the world’s most commonly used NSAID, the risk is real, according to 2 decades of Danish health data.
Cardiologists and pulmonologists should collaborate to better identify the relationship between lung function decline and early CV disease...
MUNICH – By endorsing high sensitivity cardiac troponin and cardiac MR as diagnostic cornerstones, the new MI definition stands to change U.S....
An increased risk of cardiovascular adverse events and cardiovascular death was seen in COPD patients in the highest quintile of plasma cardiac...
MUNICH – No benefit for primary cardiovascular prevention seen in massive ASCEND trial.
MUNICH - Rivaroxaban did not change outcome in patients with heart failure and coronary artery disease in the COMMANDER trial.
To address concerns regarding the voluntary recall of some valsartan products, affected drugmakers and the FDA have issued advisories for...
ROCKVILLE, MD. – Strategies still are needed to fight obesity, diabetes, smoking, and sedentary behavior.